Liu Min-Ching, Jiang Yuan-Hong, Jhang Jia-Fong, Chang Tien-Lin, Yang Chia-Cheng, Kuo Hann-Chorng
Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Tzu Chi University, Hualien 970, Taiwan.
Int J Mol Sci. 2024 Nov 26;25(23):12670. doi: 10.3390/ijms252312670.
Women commonly experience urinary tract infection (UTI) recurrence. However, there is no effective tool for predicting recurrent UTI after the first UTI episode. Hence, this study aimed to investigate potential urinary inflammatory biomarkers and specific biomarkers for predicting UTI recurrence or persistence after antibiotic treatment in women. Forty women who had a history of recurrent UTI within 1 year after the initial episode and acute bacterial cystitis were treated with broad-spectrum antibiotics for 1 week. To measure inflammatory biomarker levels, urine samples were collected at the baseline and after 1 week, 1 month, and 3 months. The levels of urinary pro-inflammatory proteins such as neutrophil gelatinase-associated lipocalin (NGAL), nerve growth factor, CXC-motif chemokine ligand (CXCL)-1, interleukin-8, CXCL-10, monocyte chemoattractant protein-1, and tumor necrosis factor-alpha were measured using commercial kits. Seven healthy age-matched women were included as controls. The changes in urinary biomarker levels at the baseline and various time points were compared between women with and without UTI recurrence within 1 month or within 3 months after the initial antibiotic therapy. At the baseline, patients with a higher urinary white blood cell count had a significantly higher NGAL level than the controls and those with a low white blood cell count. Of the 40 patients with a history of recurrent UTI, 12 presented with UTI persistence or recurrence within 1 month and 19 within 3 months after the initial antibiotic treatment. Among the 28 patients without UTI recurrence at 1 month after treatment, 7 had UTI recurrence within 3 months. Compared with patients without UTI recurrence, those with UTI recurrence had significantly higher urinary NGAL levels at 1 week, 1 month, and 3 months after the initial treatment. This study concludes that persistent elevation in urinary NGAL levels after the initial antibiotic treatment indicated persistent bladder inflammation. Further, it could be a predictor of UTI persistence or recurrence within 1 or 3 months after the initial antibiotic treatment. Patients with a history of recurrent UTI and high urinary NGAL levels after antibiotic treatment might require a longer treatment duration to completely eradicate or prevent UTI recurrence.
女性经常经历尿路感染(UTI)复发。然而,在首次UTI发作后,尚无有效的工具来预测UTI复发。因此,本研究旨在调查潜在的尿液炎症生物标志物和特定生物标志物,以预测女性抗生素治疗后UTI的复发或持续情况。40名在初次发作后1年内有复发性UTI病史且患有急性细菌性膀胱炎的女性接受了1周的广谱抗生素治疗。为了测量炎症生物标志物水平,在基线以及1周、1个月和3个月后采集尿液样本。使用商业试剂盒测量尿液中促炎蛋白的水平,如中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、神经生长因子、CXC基序趋化因子配体(CXCL)-1、白细胞介素-8、CXCL-10、单核细胞趋化蛋白-1和肿瘤坏死因子-α。纳入7名年龄匹配的健康女性作为对照。比较初次抗生素治疗后1个月内或3个月内有无UTI复发的女性在基线和不同时间点尿液生物标志物水平的变化。在基线时,尿白细胞计数较高的患者的NGAL水平显著高于对照组和白细胞计数低的患者。在40名有复发性UTI病史的患者中,12名在初次抗生素治疗后1个月内出现UTI持续或复发,19名在3个月内出现。在治疗后1个月无UTI复发的28名患者中,7名在3个月内出现UTI复发。与无UTI复发的患者相比,有UTI复发的患者在初次治疗后1周、1个月和3个月时尿液NGAL水平显著更高。本研究得出结论,初次抗生素治疗后尿液NGAL水平持续升高表明膀胱炎症持续存在。此外,它可能是初次抗生素治疗后1个月或3个月内UTI持续或复发的预测指标。有复发性UTI病史且抗生素治疗后尿液NGAL水平高的患者可能需要更长的治疗时间来完全根除或预防UTI复发。